MedpaceMEDP
MEDP
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
12% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 81
12% more call options, than puts
Call options by funds: $26.1M | Put options by funds: $23.4M
3% more repeat investments, than reductions
Existing positions increased: 213 | Existing positions reduced: 206
0% more funds holding
Funds holding: 577 [Q3] → 577 (+0) [Q4]
0.25% less ownership
Funds ownership: 81.63% [Q3] → 81.38% (-0.25%) [Q4]
0% less capital invested
Capital invested by funds: $8.43B [Q3] → $8.4B (-$31.6M) [Q4]
14% less funds holding in top 10
Funds holding in top 10: 7 [Q3] → 6 (-1) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$330
11%
upside
Avg. target
$346
16%
upside
High target
$362
22%
upside
2 analyst ratings
0 positive
0%
2 neutral
100%
0 negative
0%
Leerink Partners Michael Cherny 68% 1-year accuracy 19 / 28 met price target | 11%upside $330 | Market Perform Initiated | 24 Mar 2025 |
Baird Eric Coldwell 42% 1-year accuracy 14 / 33 met price target | 22%upside $362 | Neutral Maintained | 27 Jan 2025 |
Financial journalist opinion
Based on 6 articles about MEDP published over the past 30 days
Positive
Zacks Investment Research
1 week ago
Medpace (MEDP) Outperforms Broader Market: What You Need to Know
Medpace (MEDP) closed at $330.59 in the latest trading session, marking a +1.96% move from the prior day.
Positive
Zacks Investment Research
1 week ago
CON or MEDP: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Neutral
Business Wire
2 weeks ago
Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2025 financial results after the market close on Monday, April 21, 2025. The Company will host a conference call the following morning, Tuesday, April 22, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 1.
Positive
Zacks Investment Research
3 weeks ago
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Neutral
Zacks Investment Research
3 weeks ago
Medpace (MEDP) Advances While Market Declines: Some Information for Investors
Medpace (MEDP) concluded the recent trading session at $324.13, signifying a +1.55% move from its prior day's close.
Neutral
Accesswire
4 weeks ago
An Investigation Has Been Launched Into Medpace Holdings, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Neutral
Accesswire
1 month ago
The Schall Law Firm Invites Shareholders With Losses In Medpace Holdings, Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Neutral
Accesswire
1 month ago
An Investigation Has Been Launched Into Medpace Holdings, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Neutral
Accesswire
1 month ago
The Schall Law Firm Invites Shareholders With Losses In Medpace Holdings, Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / February 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Neutral
Accesswire
1 month ago
An Investigation Has Been Launched Into Medpace Holdings, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Charts implemented using Lightweight Charts™